FDA expanded clearance for O3 monitoring use by Masimo.
2 reports, 2 independent
Updated Jun 28
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
FDA expanded clearance for O3 monitoring use by Masimo.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
Related events
- A company involving Oxford seeks FDA clearance for a new diagnostic test.
- FDA issued an Early Alert regarding a device issue involving Edwards Lifesciences.
- LabCorp is involved in FDA-approved drugs. Intuitive Surgical's systems were FDA-cleared. Masimo develops noninvasive patient monitoring technologies.